AGIO Agios Pharmaceuticals PE ratio, current and historical analysis
As of Feb 21, 2025, the AGIO stock has a PE ratio of 2.97. The calculation is based on the latest EPS of $11.86 and the stock price of $35.22 per share.
AGIO PE ratio history
The mean historical PE ratio of Agios Pharmaceuticals over the last four years is 2.42. The current 2.97 P/E ratio is 23% higher than the historical average. Looking back at the last four years, AGIO's PE ratio peaked in the Sep 2024 quarter at 3.77, with a price of $44.43 and an EPS of $11.79. The Dec 2021 quarter marked the lowest point at 1.24, with a price of $32.87 and an EPS of $26.55.
Agios Pharmaceuticals PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 2.77 | N/A | $32.86 | $11.86 |
| 2023 | N/A | N/A | $22.27 | -$6.33 |
| 2022 | N/A | N/A | $28.08 | -$4.23 |
| 2021 | 1.24 | N/A | $32.87 | $26.55 |
| 2020 | N/A | N/A | $43.33 | -$4.74 |
| 2019 | N/A | N/A | $47.75 | -$6.86 |
| 2018 | N/A | N/A | $46.11 | -$6.03 |
| 2017 | N/A | N/A | $57.17 | -$6.75 |
| 2016 | N/A | N/A | $41.73 | -$5.07 |
| 2015 | N/A | N/A | $64.92 | -$3.15 |
| 2014 | N/A | N/A | $112.04 | -$1.59 |
| 2013 | N/A | N/A | $23.95 | -$2.83 |
| 2012 | N/A | N/A | N/A | -$8.02 |
| 2011 | N/A | N/A | N/A | -$8.9 |
Agios Pharmaceuticals PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 2.77 | -26.53% | $32.86 | $11.86 |
| Sep 2024 | 3.77 | N/A | $44.43 | $11.79 |
| Jun 2024 | N/A | N/A | $43.12 | -$6.5 |
| Mar 2024 | N/A | N/A | $29.24 | -$6.32 |
| Dec 2023 | N/A | N/A | $22.27 | -$6.33 |
| Sep 2023 | N/A | N/A | $24.75 | -$3.95 |
| Jun 2023 | N/A | N/A | $28.32 | -$3.8 |
| Mar 2023 | N/A | N/A | $22.97 | -$3.97 |
| Dec 2022 | N/A | N/A | $28.08 | -$4.23 |
| Sep 2022 | N/A | N/A | $28.28 | -$5.55 |
| Jun 2022 | N/A | N/A | $22.17 | -$5.62 |
| Mar 2022 | N/A | N/A | $29.11 | -$5.35 |
| Dec 2021 | 1.24 | -39.22% | $32.87 | $26.55 |
| Sep 2021 | 2.04 | -16.05% | $46.15 | $22.57 |
| Jun 2021 | 2.43 | 7.52% | $55.11 | $22.7 |
AGIO average PE ratio chart
The current PE ratio of AGIO is higher than its 5 and 10-year averages.
AGIO PE vs peers
AGIO's PE ratio stands lower than its peer stocks LLY and PFE. Agios Pharmaceuticals's current PE ratio of 2.97 is lower than the average of its peers, which is 42.38.
| Stock name | PE ratio | Market cap |
|---|---|---|
| AGIO Agios Pharmaceuticals Inc | 2.97 | $2.02B |
| EXEL Exelixis Inc | 20.47 | $10.31B |
| PFE Pfizer Inc | 34.61 | $149.04B |
| BMRN Biomarin Pharmaceutical Inc | 40.15 | $13.01B |
| LLY ELI LILLY & Co | 74.29 | $828.4B |
| XNCR Xencor Inc | N/A | $1.1B |
Frequently asked questions
What is Agios Pharmaceuticals's PE ratio?
The price to earnings ratio for AGIO stock is 2.97 as of Feb 21, 2025.
What is the 5-year average PE ratio for Agios Pharmaceuticals (AGIO)?
The 5-year average price to earnings ratio for AGIO stock is 2.42.
What is the highest PE ratio for AGIO?
Over the last four years, the Sep 2024 quarter recorded the highest quarterly PE ratio at 3.77.
How does the current PE ratio for AGIO compare to its historical average?
AGIO's current price to earnings ratio is 23% above its 4-year historical average.
Why is Agios Pharmaceuticals's PE ratio so low?
AGIO's PE ratio is low because its earnings per share (EPS) is high relative to its stock price.
How is AGIO's PE ratio calculated (Agios Pharmaceuticals PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Feb 21, 2025), Agios Pharmaceuticals's share price is $35.22. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $11.86. Therefore, Agios Pharmaceuticals's PE ratio for today is 2.97. PE RATIO(2.97) = STOCK PRICE($35.22) / TTM EPS($11.86)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.